CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
76 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $168M → $155M (-$13.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
76
Holding in Top 10
1
Calls
$123K
Puts
$65K
Top Buyers
| 1 | +$5.2M | |
| 2 | +$1.67M | |
| 3 | +$1.42M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$1.41M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.4M |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$3.31M | |
| 3 | -$1.56M | |
| 4 |
Millennium Management
New York
|
-$1.42M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.25M |